VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Overview Fund Activity
Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

24 hedge funds and large institutions have $63.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
5
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$853K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$658K
3
VKH
3
Virtu KCG Holdings
New York
$512K
4
EI
4
EAM Investors
California
$414K
5
Goldman Sachs
5
Goldman Sachs
New York
$383K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$996K
2
Cambridge Investment Research Advisors
2
Cambridge Investment Research Advisors
Iowa
$7.56M
3
PP
3
Paloma Partners
Connecticut
$0
4
Deutsche Bank
4
Deutsche Bank
Germany
$0
5
UBS Group
5
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– -$9K -94 Closed
Walleye Trading
27
Walleye Trading
New York
– -$7K -79 Closed
Bank of America
28
Bank of America
North Carolina
– -$4K -43 Closed
1
2